Embeddedadvisor
US
APAC
EUROPE
  • Home
  • Insights
  • Whitepaper
  • Conferences
  • Newsletter
  • Subscribe
  • News
  • About us
Go to...
  • Home
  • Insights
  • Whitepaper
  • Conferences
  • Newsletter
  • Subscribe
  • News
  • About us
  • Categories

  • IP Design
  • Telecom
  • Wearables and Sensor
  • Consumer Electronics
  • IoT
  • More
      • Industrial Computing
Go to...
  • Categories

  • IP Design
  • Telecom
  • Wearables/Sensor
  • Consumer Electronics
  • IoT
  • Industrial Computing
×
#

Embedded Advisor Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Embedded Advisor

Subscribe

loading

THANK YOU FOR SUBSCRIBING

  • Home
  • Insights
  • Medical Devices
Editor's Pick(1 - 4 of 8)
left
The Changing Role of CIO in the Biopharmaceutical Industry

Andy Newsom, CIO, CSL Behring

Automation Leading the Change in Healthcare

Rick Schooler, VP & CIO, Orlando Health

Keeping Up with the Latest Medical Trends

Joseph G Seay, Former SVP & CIO, Community Health Systems

Making Healthcare Better Through Mobile Innovation

Bijoy Sagar, Global CIO, Stryker

Innovations that Enhance Public Healthcare

John Kravitz, CIO, Geisinger

Making Digital Health a Primary rather than an Additive Solution

Jennifer Briley Christian, Vice President, Clinical Evidence, IQVIA [NYSE: IQV]

Recent Trend and Development in Pharmaceutical Industry

Richard Hu, Associate Director CMC, Curis, Inc. [NASDAQ: CRIS]

Strong Business- HR Partnerships, Coupled With Technology, Help Drive Talent Agenda

Cindy Carlisle, VP, HR. Commercial Operations, Roche Diagnostics Corporation

right

Next-Generation Commercial Data Management Systems for Biopharmaceuticals

By Ashwin Athri, SVP, Precision for Value

Tweet

Ashwin Athri, SVP, Precision for Value

How often is there a business-critical problem statement that requires analysis of various data assets that you have invested time and money to procure and manage, and you hear from the team that:

• The data don’t really talk to each other that way

• You need to hire consultants to make sense of the data

• The data aren’t organized in a way to answer that question

• It’s going to take a few months to get the system to generate the results the way you need to

The speed to insight is one of the most common challenges decision makers face in an age where we are inundated with data. Teams often spend more time cleaning and organizing the data assets than generating insight from them. Why is it that when we have infrastructure to store large data and enterprise platforms for visualization and reporting, as well as advanced analytic teams, that we still struggle to meet these needs?

The answer may actually lie in small data. Counterintuitive?

The discipline of master data management (MDM) has gained momentum in biopharma recently. There is a lot of activity in the space, with companies developing sophisticated systems and IT departments implementing the solution across organizations.

Across the Biopharmaceutical industry, the data assets that are commonly leveraged for commercial business insights and analytics include:

• Third-party: Prescriptions, medical claims, patient longitudinal, formulary coverage and restrictions, shipment, distribution

• Second-party: Contract rebate submissions, specialty pharmacy, copay card redemption, EMR

• First-party: HUB, CRM, media; such as web, mobile, email, medical devices, sales, and territory alignments

There are a few key aspects of the data assets, common to all manufacturers, which need to be organized across these types of data sets to enable insight generation and innovation. A few of these parameters that we need to master and leverage for integration are:

• Payers: PBMs, health plans, employers, unions

• Providers: Hospitals, practices, IDNs, infusion centers, cancer centers

• HCPs: Primary address, employment, affiliations

• Products: Market baskets, indications, brands

• Treatments: NDC, ICD, HCPCS

If every manufacturer sets out to solve the same problem across the same data assets, the industry is investing on the same solution multiple times on the same outcome, which does not give any manufacturer a decisive competitive advantage. This is not a very efficient use of capital.

"The discipline of master data management (MDM) has gained momentum in biopharma recently"

A traditional approach to an MDM solution is to use a sophisticated software system that figures out the data map as you continue to feed it data. There are a couple of challenges that this presents, including that these systems are often developed pan-industry, and they come loaded with features and capabilities that the teams barely use as they are not mission critical. These over-engineered solutions are then leveraged to solve a problem statement that should, by nature, be a solved problem. Running and managing these systems adds another layer to the already large lead-time to insight. We need a better approach. This is not scenario for an engineering solution, this calls for a business solution that leverages available technology.

How payers and providers organize themselves and the capabilities they have, is often independent of a manufacturer’s product or even the therapeutic area. These payers, HCPs, and providers exist and operate in the marketplace regardless of the manufacturer. There is a more universal truth that needs to be first understood and applied before applying the data assets for analysis.

Industry standard reference files, with centralized stewardship and governance that contain business intelligence along with attributes that enrich the data itself, are now necessary to provide the solution than relying on systems to figure it out. These are small data coming to the rescue of the big data mire. Small data helps lakes not become swamps. Small data ensures the ROI on big data investments. Small data ensures the large systems that you built and maintain are leveraged optimally.

Imagine having a turnkey data universe where the payer, provider and HCP names, relationships, and hierarchies are cross-asset, ready with all of all attributes, such as 340B institutions with in-office dispensing, EMR systems used at site of care, employer and unions tied to prescription claims, payer archetypes, and IDN maturity models from the get-go. All of this regardless and independent of the data vendor(s) you choose to purchase from. Now you are ready to derive insights. Now the data asset is primed to provide business intelligence at the speed you need to run the business. Now you can turn data into a competitive advantage.

Check out: Semiconductor Review

tag

ROI

Read Also

Innovations that Enhance Public Healthcare

Innovations that Enhance Public Healthcare

John Kravitz, CIO, Geisinger
Making Digital Health a Primary rather than an Additive Solution

Making Digital Health a Primary rather than an Additive Solution

Jennifer Briley Christian, Vice President, Clinical Evidence, IQVIA [NYSE: IQV]
Recent Trend and Development in Pharmaceutical Industry

Recent Trend and Development in Pharmaceutical Industry

Richard Hu, Associate Director CMC, Curis, Inc. [NASDAQ: CRIS]
Strong Business- HR Partnerships, Coupled With Technology, Help Drive Talent Agenda

Strong Business- HR Partnerships, Coupled With Technology, Help Drive Talent Agenda

Cindy Carlisle, VP, HR. Commercial Operations, Roche Diagnostics Corporation

Weekly Brief

loading
Top 10 Medical Devices Design and Solutions Companies - 2019

Medical Devices Special

Featured Vendors

  • ANSYS [NASDAQ:ANSS]: Modeling Human Body with Simulation Software
    ANSYS [NASDAQ:ANSS]: Modeling Human Body with Simulation Software
  • ADM Tronics Unlimited, Inc. [OTC:ADMT]: Transforming Care with Innovative Medical Technologies
    ADM Tronics Unlimited, Inc. [OTC:ADMT]: Transforming Care with Innovative Medical Technologies
  • DFI-ITOX:  High-Performance Medical Computing Devices
    DFI-ITOX: High-Performance Medical Computing Devices
  • OrthoSensor: Advanced Sensor-Assisted Technology for a Balanced Total Knee Replacement
    OrthoSensor: Advanced Sensor-Assisted Technology for a Balanced Total Knee Replacement

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Copyright © 2021 Embedded Advisor. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy Policy.
follow on linkedin follow on twitter
This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

medical-devices.embeddedadvisor.com/cxoinsights/nextgeneration-commercial-data-management-systems-for-biopharmaceuticals-nid-451.html?utm_source=google&utm_campaign=embeddedadvisor_topslider